Elastography Imaging Market Worth $3.5 Billion By 2026

The global elastography imaging market size is expected to reach USD 3.5 billion by the end of 2026, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR over the forecast period. Increasing incidence of breast cancer and chronic liver disorders is expected to significantly drive the market. Additionally, increasing demand for minimally-invasive procedures and ongoing studies to assess the potential applications of elastography are factors expected to contribute toward rapid growth.

Currently elastography has wide applications in assessing breasts, thyroid, prostate, and liver. Increasing number of ongoing studies are expected to increase its applications in diagnosis of various conditions such neurodegenerative disorders and chronic kidney diseases. It has shown promising results for its use in assessment of kidney health during and after transplantation.

North America dominated the market in 2018 and is expected to continue its dominance during the forecast period. The elastography imaging market growth observed in the region is due to the presence of a large number of global players, along with high adoption rate for advanced imaging techniques.

Growing strategic alliances among players for development and distribution of products is expected to propel the market during the forecast period. Moreover, development of new surgical centers in different locations will increase the adoption of advanced imaging systems.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/elastography-imaging-market

Further key findings from the report suggest:

By modality, the ultrasound segment is predicted to register significant growth during the forecast period owing to advantages such as low price, accessibility, and high degree of measurement for tissue deformation
On the basis of end use, the hospital segment is anticipated to hold the largest share in the market during the forecast period due to rising number of ultrasound and MRI-based elastography procedures and growing trends of hospital-based imaging facilities
By way of application, the radiology domain is predicted to hold a large share in the market over the forecast period owing to increase in demand in image-guided radiotherapy and radiology ultrasound
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare facilities and rising geriatric population who are prone to developing targeted disorders
Major players in the elastography imaging industry are focusing on growth strategies such as partnerships, collaborations, mergers, and acquisitions. Some of the leading players are Esaote SpA; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Hitachi, Ltd.; GE Healthcare; Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers; Toshiba America Medical Systems, Inc.; and Samsung Medison Co., Ltd.

Medical Device Outsourcing Market Size Worth $231.2 Billion By 2027

The global medical device outsourcing market size is expected to reach USD 231.2 billion by 2027, expanding at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The growing incidence of chronic diseases is one of the major factors contributing to market growth. Regulatory bodies are mainly focusing on the quality of the healthcare devices provided to the public. Hence this is encouraging various players in the market to offer various services like regulatory consulting. For example, the European Medical Device Regulation undertake special spontaneous inspection of outsourced products to test the quality as well as conformity with standards.

The importance of regulatory compliance is expected to boost the growth of consulting services such as remediation, compliance, and quality management systems (QMS), thereby contributing to market growth. Whereas, the budget scrutiny in developed countries, pricing pressure, and changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by the original equipment manufacturers (OEM). These factors are expected to boost medical device outsourcing to emerging countries like India and China.

In addition, increasing difficulties in product engineering along with new entrants in the market are anticipated to shape the future of the market for medical device outsourcing. Whereas rising prevalence of chronic diseases is boosting the demand for medical devices. This, in turn, is helping the market to grow during the forecast period. Various companies are shifting their focus to research and development of new medical devices and are therefore outsourcing these activities to launch efficient medical devices in the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-device-outsourcing-market

Further key findings from the report suggest:

Contract manufacturing accounted for the largest share in service segment in 2019, due to increasing trend of outsourcing, especially in emerging countries
The quality assurance segmentis expected to witness the highest CAGR over the forecast period
Asia Pacific dominated the medical device outsourcing market with the largest share in 2019. Increasing demand for new technologies along with advanced healthcare infrastructure are likely to facilitate the dominance of this region in the market for medical device outsourcing during the forecast period
North America is projected to witness the fastest growth during the forecast period owing to increasing prevalence of chronic diseases in this region
Some of the key market players are SGS SA; TOXIKON, INC.; EUROFINS SCIENTIFIC; and PACE ANALYTICAL SERVICES, LLC.

Elastography Imaging Market Worth $3.5 Billion By 2026

Click the link below:
https://www.grandviewresearch.com/industry-analysis/elastography-imaging-market

Further key findings from the report suggest:

In 2018, non-cold chain logistics held the largest market share in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
Cold chain logistics segment is expected to register the faster CAGR over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
Warehousing and storage held the largest market share among the types of services in 2018
Asia pacific expected to emerge with the fastest CAGR over the forecast period owing to adoption of medicines from aging population and shift of drug sales from brand manufacturers to generic
Key players operating in the biopharmaceutical third party logistics market include DHL International GmbH., SF Express, United Parcel Service of America, Inc, AmerisourceBergen Corporation, DB Schenker, Kuehne and Nagel, Kerry logistics network limited and AgilityBy modality, the ultrasound segment is predicted to register significant growth during the forecast period owing to advantages such as low price, accessibility, and high degree of measurement for tissue deformation
On the basis of end use, the hospital segment is anticipated to hold the largest share in the market during the forecast period due to rising number of ultrasound and MRI-based elastography procedures and growing trends of hospital-based imaging facilities
By way of application, the radiology domain is predicted to hold a large share in the market over the forecast period owing to increase in demand in image-guided radiotherapy and radiology ultrasound
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare facilities and rising geriatric population who are prone to developing targeted disorders
Major players in the elastography imaging industry are focusing on growth strategies such as partnerships, collaborations, mergers, and acquisitions. Some of the leading players are Esaote SpA; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Hitachi, Ltd.; GE Healthcare; Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers; Toshiba America Medical Systems, Inc.; and Samsung Medison Co., Ltd.

Hybrid Imaging Market Size Worth $9.8 Billion By 2026

The global hybrid imaging market size is expected to reach USD 9.8 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.5% CAGR over the forecast period. Increasing demand for accurate diagnostic techniques for cancer and cardiac disorders is expected to drive the market. Rising government initiatives for creating awareness regarding multimodal imaging devices are also expected to contribute toward market growth.

Increasing installation of such devices in research centers and institutions to enhance diagnostics in the field of oncology, cardiology, neurology, and others is expected to boost market growth. Leading players in the market are showcasing various multimodal imaging devices at medical conferences to increase their product reach. However, high cost and complications associated with these devices is expected to impede market growth during the forecast period.

Hybrid imaging devices require skilled professionals to understand the data collected by these combined devices. Therefore, various training programmes are conducted by several non-profit and government funded organizations to increase the adoption of hybrid imaging devices for the diagnosis of a disease.

North America dominated the hybrid/multimodal imaging market in 2018 and is expected to grow at a significant rate during the forecast period. The growth observed in this region is largely due to presence of global players and increasing adoption of advanced equipment such as hybrid imaging devices. Moreover, increasing awareness regarding nuclear medicine and molecular diagnostics in the region is expected to contribute toward the growth in this region.

Asia Pacific is expected register the strongest growth over the forecast period. This can be primarily attributed to growing usage of advanced devices such as PET/CT systems in radiology departments across emerging economies. Thriving medical tourism in numerous countries has piqued the interest of global market players, who are looking to invest in the development and launch of advanced software in the region. The Europe market is fueled by ongoing efforts by various non-profit organizations in conducting educational and training programs for scientists, physicians, technologists, physicists, radiographers, and others in the field.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/hybrid-imaging-market

Further key findings from the report suggest:

PET/CT systems held the largest share in 2018 based on type, and the segment is expected to grow at a significant pace due to increasing development and installation of these devices in various end users such as hospitals and diagnostic centers
SPET/CT systems segment in hybrid imaging market will exhibit the fastest growth rate during the forecast period. Data captured by SPET/CT helps in understanding the detailed morphology and pathogenesis of a disease, thereby enhancing the quality of diagnostic output
In 2018, the oncology segment held the dominant share of hybrid imaging systems market by application, largely due to increasing number of cancer cases and growing awareness for cancer diagnosis
The cardiology segment is expected to grow at the fastest pace during the forecast period. Cardiac hybrid imaging helps in accurately capturing morphological and functional information in a single setting, thereby easing the diagnosis of cardiac disorders
Hospitals held the largest market share in 2018 on the basis of end use, mainly due to higher installation of technologically advanced devices for early diagnosis and treatment of a disease
Geographically, Asia Pacific is expected to register the fastest growth rate during the forecast period due to increasing number of radiology departments in the region and launch of advanced software by leading players.

Latin America In Vitro Diagnostics Market Size To Reach $5.1 Billion By 2024

The latin america IVD market is expected to reach over USD 5.1 billion by 2024, according to a new report by Grand View Research, Inc. The Latin America IVD market is expected to grow at a significant CAGR till 2024 owing to the rising prevalence of target disorders, aging population, and the presence of favorable government initiatives for early disease diagnosis. Other factors that are anticipated to boost the growth include the introduction of technologically advanced instruments and the increasing R&D initiatives for the development of disease-specific kits.

Regular testing for diabetes, cardiovascular, cancer, and sexually transmitted diseases are necessary for the timely treatments, further avoiding the risk of fatal health complications. The availability of tests for home and near patient testing is estimated to further enhance the usage rates of these devices. From November 2015, the Anvisa, which is a regulatory body for medical devices in Brazil, has started allowing the registration for HIV self-testing kits.

The increasing adoption point of care devices coupled with the increasing awareness among the healthcare professionals regarding the early diagnosis of various diseases has provided a boost to the Latin IVD market. The rising epidemic of communicable diseases in the southernpart of Latin America, the growing need for rapid and accurate diagnostics, and the changing healthcare infrastructure scenario are some of the key drivers of the Latin IVD market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/latin-america-in-vitro-diagnostics-ivd-market

Further key findings from the study suggest:

The instrument segment is one of the most important segments of in vitro diagnostics. The presence of highly automated analyzers and the availability of over the counter products are some of the factors responsible for its significant share.
The Molecular diagnostics segment is anticipated to be the fastest growing technology over the decade. Molecular diagnostics is a transformative area of diagnostics. The continuous innovation in technology helps the physicians for critical decision making
The infectious disease segment held the largest share in 2015 over 24% owing to the presence of favorable government initiatives in association with the WHO to curb communicable diseases.
The home care segment is estimated to witness a significant growth over the forecast period. The high number of R&D initiatives undertaken by key competitors for the development of portable IVD devices with improved sensitivity and user-friendliness is a key factor attributing towards its growth.
In 2015, Brazil was the largest regional segment with a revenue generation of over USD 1.2 billion owing to the established healthcare infrastructure, growing awareness for cancer screening, and the increasing demand for genetic testing.
Peru is expected to be one of the fastest growing regions on account of the growing economic stability, high unmet clinical needs, and the rising disposable incomes
Key players operating in the Latin America IVD market are Roche Diagnostics, Abbott Laboratories, Inc., Hologic (Gen-Probe), Becton Dickinson (BD) Company, Alere, Inc., Bio-Rad Laboratories, Qiagen N.V., Inc., bioMerieux, BioQuidel Corporation, and Siemens Healthcare.

Pediatric Imaging Market Worth $12.2 Billion By 2027

The global pediatric imaging market size is expected to reach USD 12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing incidences of pediatric trauma cases are expected to accelerate the demand for innovative patient screening, which is expected to augment the market growth.

According to the Centers for Disease Control and Prevention (CDC), an estimated 812,000 children aged 17 or below were treated in the U.S. Emergency Department (ED) for concussion or Traumatic Brain Injury (TBI) in 2014. CDC further stated that injuries due to falling accounted for an approximate 49% of all TBI-related ED visits in children. In addition, increasing focus of market players on product development and innovation is expected to drive the market growth. For instance, in June 2019, Carestream Health, Inc. launched a portable Carestream DRX Plus 2530C X-ray detector with cesium iodide technology, which captures minute details of anatomical structures in pediatric patients.

North America accounted for the largest share in 2019 owing to favorable reimbursement policies, faster adoption of innovative imaging modalities, and growing consumer preference toward noninvasive diagnosis. Increasing investments in order to propel technological innovation is expected to augment the pediatric imaging market growth in the region. For instance, in 2018, Bracco Diagnostics Inc. provided a grant of USD 300,000 to Children’s Hospital of Philadelphia (CHOP), to fund research and train technicians to use a new technology of contrast ultrasound. Also, medical coverage is granted by the Children’s Health Insurance Program (CHIP) for pediatric patients in U.S., which covers imaging services, is a major factor propelling the market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/pediatric-imaging-market

Further key findings from the report suggest:

The magnetic resonance imaging modality segment dominated the market owing to high usage in hospital settings and higher recommendations by radiologists due to safety
By application, the orthopedic/ trauma segment is expected to register the highest CAGR due to rising incidence of bone defects in children combined with increasing cases of ED visits related to trauma
By end user, the hospital segment accounted for the largest market share owing to large number of installed systems in hospital settings and direct collaborations of hospitals with market vendors, thereby offering access to novel and advanced imaging systems
Leading players present in the pediatric imaging market include GE Healthcare; Siemens Healthineers AG; Koninklijke Philips N.V. (Royal Philips); Fujifilm Holdings Corporation; Toshiba Medical Systems Corporation; Samsung Electronics Co., Ltd.; Agfa Healthcare; and Carestream Health, Inc.

3D Medical Imaging Devices Market Size Worth $20.8 Billion By 2026

The global 3d medical imaging devices market size is expected to reach USD 20.8 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 5.9% during the forecast period. High prevalence of cancer, cardiovascular diseases, and Alzheimer’s among other chronic diseases is projected to drive the growth. Rise in healthcare expenditure across developed economies and rapid technological advancements are other prime factors responsible for the market growth.

Few noteworthy technological advancements include development of imaging systems with low radiation levels and increasing approvals of contrast and media/agents. For instance, in April 2016, Bracco Diagnostics, a U.S. based subsidiary of Bracco Imaging S.p.A., an Italian giant in the 3D imaging; received approval from the U.S. Food and Drug Administration (FDA) for its new ultrasound contrast agent Lumason, for pediatric and adult patients. In another instance, Germany based healthcare company, Bayer Healthcare received FDA approval in May 2016 for Gadovist injection used in the angiography procedures in U.S. Such factors are expected to bode well for the global market growth over the forecast period.

However, the 3D medical imaging devices market is restrained due to the high cost of devices and the shortage of helium used in the cooling of MRI scanners.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/3d-medical-imaging-devices-market

Further key findings from the study suggest:

By type, computed tomography emerged as the largest segment in 2017 owing to the rise in road traffic accidents
Orthopedic led the application segment owing to the global rise in old age population with musculoskeletal problems
Rise in healthcare expenditure in emerging markets, such as India and China coupled with awareness regarding early diagnosis are key factors propelling growth of the 3D medical imaging devices market
North America held the largest market share in 2017. Growing adoption of minimally invasive surgeries and demand for novel technologies are expected to support this dominance during the forecast period
Asia Pacific is projected to witness swift growth during the forecast period owing to the rapidly improving healthcare infrastructure and the presence of large patient population
Few of the key market players include Siemens Healthineers; Philips Koninklijke; GE Healthcare Ltd.; Hitachi Medical Systems; Del Medical Systems Inc.; and DigiRad Corporation.